Cargando…
Impact of Revised Broad-Spectrum Cephalosporin Clinical and Laboratory Standards Institute Breakpoints on Susceptibility in Enterobacteriaceae Producing AmpC β-Lactamase
We evaluated the impact of revised Clinical and Laboratory Standards Institute (CLSI) breakpoints for broad-spectrum cephalosporins (BSCs) on the susceptibilities of 1,742 isolates of Enterobacter species, Serratia marcescens, Citrobacter freundii, and Morganella morganii. The 2011 CLSI criteria for...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Infectious Diseases and Korean Society for Chemotherapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382052/ https://www.ncbi.nlm.nih.gov/pubmed/28271652 http://dx.doi.org/10.3947/ic.2017.49.1.62 |
_version_ | 1782520038051282944 |
---|---|
author | Park, Ki-Ho Chong, Yong Pil Kim, Sung-Han Lee, Sang-Oh Lee, Mi Suk Sung, Heungsup Kim, Mi-Na Kim, Yang Soo Woo, Jun Hee Choi, Sang-Ho |
author_facet | Park, Ki-Ho Chong, Yong Pil Kim, Sung-Han Lee, Sang-Oh Lee, Mi Suk Sung, Heungsup Kim, Mi-Na Kim, Yang Soo Woo, Jun Hee Choi, Sang-Ho |
author_sort | Park, Ki-Ho |
collection | PubMed |
description | We evaluated the impact of revised Clinical and Laboratory Standards Institute (CLSI) breakpoints for broad-spectrum cephalosporins (BSCs) on the susceptibilities of 1,742 isolates of Enterobacter species, Serratia marcescens, Citrobacter freundii, and Morganella morganii. The 2011 CLSI criteria for cefotaxime and ceftazidime reduced the rates of susceptibility by 2.9% and 5.9%, respectively. The 2014 CLSI criteria for cefepime reduced the rate of susceptibility by 13.9%, and categorized 11.8% isolates as susceptible-dose dependent (SDD) for cefepime. Among 183 isolates with extended-spectrum ß-lactamase (ESBL) phenotype, implementation of the new criteria reduced the rates of susceptibility to cefotaxime, ceftazidime, and cefepime by 2.8%, 14.8%, and 53.6%, respectively. The proportion of ESBL phenotype among BSC-susceptible isolates was low (0.9% for cefotaxime, 3.0% for ceftazidime, and 3.3% for cefepime). In summary, implementation of new CLSI criteria led to little change in susceptibility to cefotaxime and ceftazidime but a substantial change in susceptibility to cefepime. The recognition of revised CLSI criteria for BSC and SDD will help clinicians to select the optimal antibiotic and dosing regimen. |
format | Online Article Text |
id | pubmed-5382052 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | The Korean Society of Infectious Diseases and Korean Society for Chemotherapy |
record_format | MEDLINE/PubMed |
spelling | pubmed-53820522017-04-06 Impact of Revised Broad-Spectrum Cephalosporin Clinical and Laboratory Standards Institute Breakpoints on Susceptibility in Enterobacteriaceae Producing AmpC β-Lactamase Park, Ki-Ho Chong, Yong Pil Kim, Sung-Han Lee, Sang-Oh Lee, Mi Suk Sung, Heungsup Kim, Mi-Na Kim, Yang Soo Woo, Jun Hee Choi, Sang-Ho Infect Chemother Brief Communication We evaluated the impact of revised Clinical and Laboratory Standards Institute (CLSI) breakpoints for broad-spectrum cephalosporins (BSCs) on the susceptibilities of 1,742 isolates of Enterobacter species, Serratia marcescens, Citrobacter freundii, and Morganella morganii. The 2011 CLSI criteria for cefotaxime and ceftazidime reduced the rates of susceptibility by 2.9% and 5.9%, respectively. The 2014 CLSI criteria for cefepime reduced the rate of susceptibility by 13.9%, and categorized 11.8% isolates as susceptible-dose dependent (SDD) for cefepime. Among 183 isolates with extended-spectrum ß-lactamase (ESBL) phenotype, implementation of the new criteria reduced the rates of susceptibility to cefotaxime, ceftazidime, and cefepime by 2.8%, 14.8%, and 53.6%, respectively. The proportion of ESBL phenotype among BSC-susceptible isolates was low (0.9% for cefotaxime, 3.0% for ceftazidime, and 3.3% for cefepime). In summary, implementation of new CLSI criteria led to little change in susceptibility to cefotaxime and ceftazidime but a substantial change in susceptibility to cefepime. The recognition of revised CLSI criteria for BSC and SDD will help clinicians to select the optimal antibiotic and dosing regimen. The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2017-03 2017-02-28 /pmc/articles/PMC5382052/ /pubmed/28271652 http://dx.doi.org/10.3947/ic.2017.49.1.62 Text en Copyright © 2017 by The Korean Society of Infectious Diseases and Korean Society for Chemotherapy http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Brief Communication Park, Ki-Ho Chong, Yong Pil Kim, Sung-Han Lee, Sang-Oh Lee, Mi Suk Sung, Heungsup Kim, Mi-Na Kim, Yang Soo Woo, Jun Hee Choi, Sang-Ho Impact of Revised Broad-Spectrum Cephalosporin Clinical and Laboratory Standards Institute Breakpoints on Susceptibility in Enterobacteriaceae Producing AmpC β-Lactamase |
title | Impact of Revised Broad-Spectrum Cephalosporin Clinical and Laboratory Standards Institute Breakpoints on Susceptibility in Enterobacteriaceae Producing AmpC β-Lactamase |
title_full | Impact of Revised Broad-Spectrum Cephalosporin Clinical and Laboratory Standards Institute Breakpoints on Susceptibility in Enterobacteriaceae Producing AmpC β-Lactamase |
title_fullStr | Impact of Revised Broad-Spectrum Cephalosporin Clinical and Laboratory Standards Institute Breakpoints on Susceptibility in Enterobacteriaceae Producing AmpC β-Lactamase |
title_full_unstemmed | Impact of Revised Broad-Spectrum Cephalosporin Clinical and Laboratory Standards Institute Breakpoints on Susceptibility in Enterobacteriaceae Producing AmpC β-Lactamase |
title_short | Impact of Revised Broad-Spectrum Cephalosporin Clinical and Laboratory Standards Institute Breakpoints on Susceptibility in Enterobacteriaceae Producing AmpC β-Lactamase |
title_sort | impact of revised broad-spectrum cephalosporin clinical and laboratory standards institute breakpoints on susceptibility in enterobacteriaceae producing ampc β-lactamase |
topic | Brief Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382052/ https://www.ncbi.nlm.nih.gov/pubmed/28271652 http://dx.doi.org/10.3947/ic.2017.49.1.62 |
work_keys_str_mv | AT parkkiho impactofrevisedbroadspectrumcephalosporinclinicalandlaboratorystandardsinstitutebreakpointsonsusceptibilityinenterobacteriaceaeproducingampcblactamase AT chongyongpil impactofrevisedbroadspectrumcephalosporinclinicalandlaboratorystandardsinstitutebreakpointsonsusceptibilityinenterobacteriaceaeproducingampcblactamase AT kimsunghan impactofrevisedbroadspectrumcephalosporinclinicalandlaboratorystandardsinstitutebreakpointsonsusceptibilityinenterobacteriaceaeproducingampcblactamase AT leesangoh impactofrevisedbroadspectrumcephalosporinclinicalandlaboratorystandardsinstitutebreakpointsonsusceptibilityinenterobacteriaceaeproducingampcblactamase AT leemisuk impactofrevisedbroadspectrumcephalosporinclinicalandlaboratorystandardsinstitutebreakpointsonsusceptibilityinenterobacteriaceaeproducingampcblactamase AT sungheungsup impactofrevisedbroadspectrumcephalosporinclinicalandlaboratorystandardsinstitutebreakpointsonsusceptibilityinenterobacteriaceaeproducingampcblactamase AT kimmina impactofrevisedbroadspectrumcephalosporinclinicalandlaboratorystandardsinstitutebreakpointsonsusceptibilityinenterobacteriaceaeproducingampcblactamase AT kimyangsoo impactofrevisedbroadspectrumcephalosporinclinicalandlaboratorystandardsinstitutebreakpointsonsusceptibilityinenterobacteriaceaeproducingampcblactamase AT woojunhee impactofrevisedbroadspectrumcephalosporinclinicalandlaboratorystandardsinstitutebreakpointsonsusceptibilityinenterobacteriaceaeproducingampcblactamase AT choisangho impactofrevisedbroadspectrumcephalosporinclinicalandlaboratorystandardsinstitutebreakpointsonsusceptibilityinenterobacteriaceaeproducingampcblactamase |